These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Testing for haemochromatosis in the diabetic clinic. George DK; Evans RM; Crofton RW; Gunn IR Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway. Bell H; Thordal C; Raknerud N; Hansen T; Bosnes V; Halvorsen R; Heier HE; Try K; Leivestad T; Thomassen Y J Hepatol; 1997 Feb; 26(2):272-9. PubMed ID: 9059946 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Velati C; Piperno A; Fargion S; Colombo S; Fiorelli G Haematologica; 1990; 75(4):309-12. PubMed ID: 2276675 [TBL] [Abstract][Full Text] [Related]
5. Screening for iron overload in the Turkish population. Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105 [TBL] [Abstract][Full Text] [Related]
6. Hereditary hemochromatosis: population screening based on phenotype in Brazilian blood donors. Barbosa KV; de Souza AF; Chebli JM; Proietti FA; Meirelles RS; de Souza JL J Clin Gastroenterol; 2005; 39(5):430-4. PubMed ID: 15815212 [TBL] [Abstract][Full Text] [Related]
7. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980 [TBL] [Abstract][Full Text] [Related]
8. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing. O'Toole R; Romeril K; Bromhead C Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068 [TBL] [Abstract][Full Text] [Related]
9. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Milman N Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989 [TBL] [Abstract][Full Text] [Related]
10. Preventing manifestations of hereditary haemochromatosis through population based screening. Haddow JE; Ledue TB J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482 [TBL] [Abstract][Full Text] [Related]
11. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198 [TBL] [Abstract][Full Text] [Related]
12. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Adams PC Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120 [TBL] [Abstract][Full Text] [Related]
18. [Prevalence of hereditary hemochromatosis among healthy workers. Diagnostic value of transferrin saturation assay]. Martínez-Vázquez C; Martínez Cadilla J; Gil M; Sopeña B; Torres J; Cordeiro E; Seijas M; de la Fuente J; Méndez MJ An Med Interna; 2000 Dec; 17(12):628-31. PubMed ID: 11213576 [TBL] [Abstract][Full Text] [Related]
20. Screening for genetic haemochromatosis in a rheumatology clinic. Olynyk J; Hall P; Ahern M; Kwiatek R; Mackinnon M Aust N Z J Med; 1994 Feb; 24(1):22-5. PubMed ID: 8002853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]